drugset / Trial / NCT07335211
Efficacy and Safety of HUC3-637 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
RandomizedParallel-groupSingle-blindTreatment
Summary
A multicenter, randomized, single-blind, active controlled, phase III clinical trial to evaluate the efficacy and safety of HUC3-637 in patients with primary open angle glaucoma or ocular hypertension
Timeline
- Start
- 2026-01
- Primary completion
- 2027-11
- Completion
- 2027-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HUC3-637 | Unknown | — | Topical |
| Comparator | HUC3-637-R | Unknown | — | Topical |